Filing Details
- Accession Number:
- 0000950170-24-115432
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-17 20:12:40
- Reporting Period:
- 2024-10-15
- Accepted Time:
- 2024-10-17 20:12:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1863127 | Tyra Biosciences Inc. | TYRA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1711463 | Todd Harris | C/O Tyra Biosciences, Inc. 2656 State Street Carlsbad CA 92008 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-10-15 | 10,035 | $24.31 | 1,467,338 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-10-16 | 4,900 | $25.22 | 1,462,438 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-10-16 | 24,475 | $26.23 | 1,437,963 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-10-16 | 3,922 | $26.98 | 1,434,041 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-10-17 | 15,194 | $25.84 | 1,418,847 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-10-17 | 200 | $26.37 | 1,418,647 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2022.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.00 to $24.8667. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $24.72 to $25.59. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $25.78 to $26.78. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.79 to $27.08. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $25.30 to $26.16. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Billionaire Hedge Funds
